Also, targeting chemokines and chemokine receptors, including CXCL9, CXCL5, CXCR1, CCR5, and CXCR4, may possibly provide a therapeutic perspective in ALI. The gene discussed is CCR5; the disease is acute respiratory distress syndrome.